Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiseman

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Arzneimittel-Forschung|October 1, 1975
Acidic antiinflammatory agents--correlations of some physical, pharmacological and clinical dataJ G Lombardino, I G Otterness, E H Wiseman
Journal of Pediatric Hematology/Oncology|April 4, 2012
Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1Daniel H Wiseman, Denise K Bonney, Robert F Wynn
Arzneimittel-Forschung|January 1, 1976
Piroxicam, a novel anti-inflammatory agentE H Wiseman, Y H Chang, J G Lombardino
FEBS Letters|November 12, 1990
Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxytamoxifen introduced into liposomes. Similarity to cholesterol and ergosterolH Wiseman, M Cannon, H R Arnstein, et al.
Trends in Biotechnology|January 13, 2000
Biomarkers, bioindicators or ecotranslators to biomonitor oestrogen mimics?A Wiseman, P S Goldfarb, T Ridgway, et al.
Clinical Pharmacology and Therapeutics|October 1, 1975
Interaction of sudoxicam and aspirin in animals and manE H Wiseman, Y H Chang, D C Hobbs
British Medical Journal (Clinical Research Ed.)|May 14, 1983
A viewdata system for poisons informationG Volans, J A Henry, J Smith, et al.
Agents and Actions|June 1, 1979
A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritisI G Otterness, E H Wiseman, D J Gans
The Biochemical Journal|June 15, 1993
Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?H Wiseman, G Paganga, C Rice-Evans, et al.
Biochimica Et Biophysica Acta|June 19, 1993
Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifenH Wiseman, M Cannon, H R Arnstein, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Arzneimittel-Forschung|October 1, 1975
Acidic antiinflammatory agents--correlations of some physical, pharmacological and clinical dataJ G Lombardino, I G Otterness, E H Wiseman
Journal of Pediatric Hematology/Oncology|April 4, 2012
Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1Daniel H Wiseman, Denise K Bonney, Robert F Wynn
Arzneimittel-Forschung|January 1, 1976
Piroxicam, a novel anti-inflammatory agentE H Wiseman, Y H Chang, J G Lombardino
FEBS Letters|November 12, 1990
Mechanism of inhibition of lipid peroxidation by tamoxifen and 4-hydroxytamoxifen introduced into liposomes. Similarity to cholesterol and ergosterolH Wiseman, M Cannon, H R Arnstein, et al.
Trends in Biotechnology|January 13, 2000
Biomarkers, bioindicators or ecotranslators to biomonitor oestrogen mimics?A Wiseman, P S Goldfarb, T Ridgway, et al.
Clinical Pharmacology and Therapeutics|October 1, 1975
Interaction of sudoxicam and aspirin in animals and manE H Wiseman, Y H Chang, D C Hobbs
British Medical Journal (Clinical Research Ed.)|May 14, 1983
A viewdata system for poisons informationG Volans, J A Henry, J Smith, et al.
Agents and Actions|June 1, 1979
A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritisI G Otterness, E H Wiseman, D J Gans
The Biochemical Journal|June 15, 1993
Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?H Wiseman, G Paganga, C Rice-Evans, et al.
Biochimica Et Biophysica Acta|June 19, 1993
Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifenH Wiseman, M Cannon, H R Arnstein, et al.
Pageof 16